Key result
African American race linked to ~33% lower CSF tau burden despite worse peripheral vascular health.
Why the study?
Alzheimer's disease rates are 64% higher in African Americans than Whites, and poor peripheral vascular function may contribute to Alzheimer's pathology and disproportionately affect African Americans.
Do CSF AD biomarkers, peripheral vascular function, and cognition differ by race in a healthy middle-aged cohort at risk for AD?
Cross-Sectional (n=82)
Do CSF AD biomarkers, peripheral vascular function, and cognition differ by race in a healthy middle-aged cohort at risk for AD?
Answers are grounded in this paper and cite their sources.
African Americans at risk for AD exhibit worse peripheral vascular health and cognition but lower CSF tau burden than Whites, suggesting race-specific differences in early AD neuropathology.
BACKGROUND: The rate of AD for African Americans (AAs) is 64% higher than for non-Hispanic White Americans (Whites). It is hypothesized that poor peripheral vascular function, in combination with genetics, stress, and inflammation may directly contribute to the accumulation of AD pathologic biomarkers. These risk factors may disproportionately affect AAs. OBJECTIVE: Our objective was to determine if in a healthy middle-aged cohort at risk for AD (1) AD biomarkers in CSF differ by race, (2) peripheral vascular dysfunction and cognition are related to a higher burden of CSF AD biomarkers, and (3) these relationships differ by race. METHODS: We enrolled 82 cognitively normal, middle-aged (45 and older) adults including AAs and Whites at high risk for AD due to parental history. Study procedures included lumbar puncture, vascular ultrasound, and cognitive testing. RESULTS: While participants were in overall good health, AAs exhibited poorer indices of preclinical vascular health, including higher central SBP, central MAP, and EndoPAT AI, a marker of arterial stiffness. AAs also had significantly less cerebrospinal fluid tau burden than Whites. After polynomial regression analysis, adjusted for age, gender, education, and ApoE4 status, race significantly modified the relationship between total tau, phospho-tau, and Trails B, a marker of executive function. Small differences in tau correlated with poorer cognition in AAs. CONCLUSION: In a healthy middle-aged cohort at risk for AD, AAs had worse peripheral vascular health and worse cognition than Whites. Despite lower tau burden overall, race modified the relationship between tau and cognition, such that small differences in tau between AAs was related to worse cognition when compared to Whites.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2020) conducted a cross-sectional in Cognitively normal adults at high risk for Alzheimer's disease (n=82). African American race vs. White race was evaluated on CSF t-tau concentration (pg/ml) (p=0.0036). African Americans had worse peripheral vascular health and cognition, but significantly lower cerebrospinal fluid tau burden compared to Whites.
Synapse has enriched 10 related papers. Consider them for comparative context: